-
EP3511317
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3511317
| EP3511317 - NEW CRYSTALLINE FORM OF SACUBITRIL SODIUM SALT [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 14.06.2024 Database last updated on 15.06.2024 | |
| Former | Grant of patent is intended Status updated on 05.10.2023 | ||
| Former | Examination is in progress Status updated on 19.02.2021 | ||
| Former | Request for examination was made Status updated on 14.06.2019 | ||
| Former | The international publication has been made Status updated on 23.03.2018 | Most recent event Tooltip | 14.06.2024 | Application deemed to be withdrawn | published on 17.07.2024 [2024/29] | Applicant(s) | For all designated states Nanjing Noratech Pharmaceuticals CO., LTD 6F, Building F6, 9 Weidi Road Jiangsu Life Science Technology Innovation Park Qixia District Nanjing City, Jiangsu Province / CN | [2020/17] |
| Former [2019/29] | For all designated states Noratech Pharmaceuticals, Inc. 12F.-5, No.760, Sec. 4, Bade Rd. Songshan Dist. Taipei City 10567 / TW | Inventor(s) | 01 /
LIU, Fei 6th Fl. F6 Building No. 9 Weidi Road Qixia District Nanjing Jiangsu 210046 / CN | 02 /
WU, Gang 6th Fl. F6 Building No. 9 Weidi Road Qixia District Nanjing Jiangsu 210046 / CN | 03 /
JIANG, Weiming 6th Fl. F6 Building No. 9 Weidi Road Qixia District Nanjing Jiangsu 210046 / CN | 04 /
LIN, Cheng-Gang 6th Fl. F6 Building No. 9 Weidi Road Qixia District Nanjing Jiangsu 210046 / CN | 05 /
CAI, Xuan 6th Fl. F6 Building No. 9 Weidi Road Qixia District Nanjing Jiangsu 210046 / CN | 06 /
LIN, Ping 6th Fl. F6 Building No. 9 Weidi Road Qixia District Nanjing Jiangsu 210046 / CN | 07 /
LU, Yuling 6th Fl. F6 Building No. 9 Weidi Road Qixia District Nanjing Jiangsu 210046 / CN | 08 /
LIU, Lixiang 6th Fl. F6 Building No. 9 Weidi Road Qixia District Nanjing Jiangsu 210046 / CN | [2019/29] | Representative(s) | Straus, Alexander, et al 2K Patent- und Rechtsanwälte - München Keltenring 9 82041 Oberhaching / DE | [N/P] |
| Former [2019/29] | Becker Kurig Straus Patentanwälte Bavariastrasse 7 80336 München / DE | Application number, filing date | 16915441.6 | 07.09.2016 | [2019/29] | WO2016CN98288 | Filing language | ZH | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2018045505 | Date: | 15.03.2018 | Language: | ZH | [2018/11] | Type: | A1 Application with search report | No.: | EP3511317 | Date: | 17.07.2019 | Language: | EN | [2019/29] | Search report(s) | International search report - published on: | CN | 15.03.2018 | (Supplementary) European search report - dispatched on: | EP | 17.03.2020 | Classification | IPC: | C07C233/51, A61K31/216, A61K31/192, A61K31/194, A61K31/195, A61P9/04, A61P9/12 | [2023/42] | CPC: |
C07C233/51 (EP);
C07C233/47 (US);
A61K31/192 (US);
A61K31/194 (US);
A61K31/195 (US);
A61K31/216 (US);
A61P9/04 (US);
A61P9/12 (US);
C07C231/12 (US);
|
| Former IPC [2020/16] | C07C233/47, A61K31/216, A61K31/192, A61K31/194, A61K31/195, A61P9/04, A61P9/12 | ||
| Former IPC [2019/29] | C07C233/47, C07C231/24, C07C231/12, A61K31/216, A61K31/192, A61K31/194, A61K31/195, A61P9/04, A61P9/12 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2019/29] | Title | German: | NEUE KRISTALLINE FORM VON SACUBITRIL-NATRIUMSALZ | [2019/29] | English: | NEW CRYSTALLINE FORM OF SACUBITRIL SODIUM SALT | [2019/29] | French: | NOUVELLE FORME CRISTALLINE DE SEL DE SODIUM DE SACUBITRIL | [2019/29] | Entry into regional phase | 05.03.2019 | Translation filed | 05.03.2019 | National basic fee paid | 05.03.2019 | Search fee paid | 05.03.2019 | Designation fee(s) paid | 05.03.2019 | Examination fee paid | Examination procedure | 05.03.2019 | Examination requested [2019/29] | 12.10.2020 | Amendment by applicant (claims and/or description) | 19.02.2021 | Despatch of a communication from the examining division (Time limit: M04) | 28.06.2021 | Reply to a communication from the examining division | 09.03.2022 | Despatch of a communication from the examining division (Time limit: M04) | 19.05.2022 | Reply to a communication from the examining division | 06.10.2023 | Communication of intention to grant the patent | 17.02.2024 | Application deemed to be withdrawn, date of legal effect [2024/29] | 11.03.2024 | Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time [2024/29] | Fees paid | Renewal fee | 05.03.2019 | Renewal fee patent year 03 | 19.08.2019 | Renewal fee patent year 04 | 31.07.2020 | Renewal fee patent year 05 | 30.08.2021 | Renewal fee patent year 06 | 29.08.2022 | Renewal fee patent year 07 | Penalty fee | Additional fee for renewal fee | 30.09.2023 | 08 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [E]WO2017097275 (ZENTIVA KS [CZ]) [E] 1-3,13-15 * pages 52-53; table 2 * * figures 2,7 ** pages 33-34; example 4a * | International search | [A]US5217996 (KSANDER GARY [US]) [A] 1-15 * , description, column 19, embodiment 1 and column 23, embodiment 8, and claims 1-11 *; | [A]CN105503638 (ZHEJIANG TIANYU PHARMACY CO LTD) [A] 1-15 * , entire document *; | [A]WO2016074651 (ZENTIVA KS [CZ]) [A] 1-15 * , description, pages 24-25, embodiment 5 and pages 26-27, embodiments 9-10, and claims 14-41 *; | [A]CN105693543 (SICHUAN HAISCO PHARMACEUTICAL CO LTD) [A] 1-15* , entire document *; | [X]CN105837464 (SICHUAN HAISCO PHARMACEUTICAL CO LTD) [X] 1-15 * , description, page 18, paragraph [0214] to page 23, paragraph [0249], figures 1-4, and claims 3-13 * | by applicant | US5217996 |